- Home
- LGCB vs EDSA Comparison
LGCB vs EDSA Comparison
Compare LGCB & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCB
- EDSA
- Stock Information
- Founded
- LGCB 2011
- EDSA 2015
- Country
- LGCB Japan
- EDSA Canada
- Employees
- LGCB N/A
- EDSA N/A
- Industry
- LGCB
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- LGCB
- EDSA Health Care
- Exchange
- LGCB Nasdaq
- EDSA Nasdaq
- Market Cap
- LGCB 6.1M
- EDSA 6.2M
- IPO Year
- LGCB 2023
- EDSA N/A
- Fundamental
- Price
- LGCB $2.41
- EDSA $1.83
- Analyst Decision
- LGCB
- EDSA Strong Buy
- Analyst Count
- LGCB 0
- EDSA 1
- Target Price
- LGCB N/A
- EDSA $21.00
- AVG Volume (30 Days)
- LGCB 28.0K
- EDSA 35.8K
- Earning Date
- LGCB 06-17-2025
- EDSA 05-14-2025
- Dividend Yield
- LGCB N/A
- EDSA N/A
- EPS Growth
- LGCB N/A
- EDSA N/A
- EPS
- LGCB N/A
- EDSA N/A
- Revenue
- LGCB $10,289,681.00
- EDSA N/A
- Revenue This Year
- LGCB N/A
- EDSA N/A
- Revenue Next Year
- LGCB N/A
- EDSA N/A
- P/E Ratio
- LGCB N/A
- EDSA N/A
- Revenue Growth
- LGCB N/A
- EDSA N/A
- 52 Week Low
- LGCB $1.22
- EDSA $1.55
- 52 Week High
- LGCB $57.05
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- LGCB 61.09
- EDSA 29.28
- Support Level
- LGCB $2.17
- EDSA $1.88
- Resistance Level
- LGCB $2.52
- EDSA $2.05
- Average True Range (ATR)
- LGCB 0.17
- EDSA 0.08
- MACD
- LGCB 0.03
- EDSA -0.00
- Stochastic Oscillator
- LGCB 73.46
- EDSA 0.00
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.